Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Corcept Therapeutics Inc’s stock clocked out at $59.42, down -2.35% from its previous closing price of $60.85. In other words, the price has decreased by -$2.35 from its previous closing price. On the day, 0.51 million shares were traded. CORT stock price reached its highest trading level at $60.0 during the session, while it also had its lowest trading level at $59.0219.
Ratios:
To gain a deeper understanding of CORT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 43.66. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Robb Gary Charles sold 2,609 shares for $56.20 per share. The transaction valued at 146,626 led to the insider holds 20,163 shares of the business.
Lyon Joseph Douglas sold 1,411 shares of CORT for $80,032 on Nov 22 ’24. The insider now owns 8,494 shares after completing the transaction at $56.72 per share. On Nov 22 ’24, another insider, Lyon Joseph Douglas, who serves as the Officer of the company, bought 1,411 shares for $56.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 6375587328 and an Enterprise Value of 5852193792. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 47.26, and their Forward P/E ratio for the next fiscal year is 31.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.90 while its Price-to-Book (P/B) ratio in mrq is 9.74. Its current Enterprise Value per Revenue stands at 9.311 whereas that against EBITDA is 40.616.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $62.22, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is 16.04%, while the 200-Day Moving Average is calculated to be 68.58%.
Shares Statistics:
It appears that CORT traded 987.17K shares on average per day over the past three months and 784950 shares per day over the past ten days. A total of 104.70M shares are outstanding, with a floating share count of 90.20M. Insiders hold about 13.91% of the company’s shares, while institutions hold 82.25% stake in the company. Shares short for CORT as of 1731628800 were 18344291 with a Short Ratio of 18.58, compared to 1728950400 on 20675546. Therefore, it implies a Short% of Shares Outstanding of 18344291 and a Short% of Float of 24.58.
